SCHEMBL3846484

SCHEMBL3846484

COc1cccc(C(=O)CC(N)=O)c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 1/20 0.67
CES2 O00748 1/20 0.61
CES1 P23141 1/20 0.61
NPC1 O15118 5/20 0.57
RAB9A P51151 5/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
POLB P06746 1/20 0.57
BLM P54132 1/20 0.57
PRSS1 P07477 1/20 0.57
PRSS2 P07478 1/20 0.57
PRSS3 P35030 1/20 0.57
KMT2A Q03164 3/20 0.56
MEN1 O00255 2/20 0.55
CHRM2 P08172 1/20 0.55
CHRM1 P11229 1/20 0.55
CHRM3 P20309 1/20 0.55
HSD11B1 P28845 1/20 0.55
HDAC3 O15379 1/20 0.52
HDAC4 P56524 1/20 0.52
HDAC1 Q13547 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL3849047 0.98 PARP1 (0.65) PARP1CES2CES1NPC1RAB9A
SCHEMBL11248287 0.90 CES2 (0.69) PARP1CES2CES1NPC1RAB9A
SCHEMBL30758862 0.90 CES2 (0.69) PARP1CES2CES1NPC1RAB9A
SCHEMBL8098826 0.85 PARP1 (0.65) PARP1CES2CES1NPC1RAB9A
SCHEMBL30626936 0.85 CES2 (0.62) PARP1CES2CES1NPC1RAB9A
SCHEMBL2130116 0.85 CES2 (0.62) PARP1CES2CES1NPC1RAB9A
SCHEMBL8889322 0.85 KMT2A (0.68) PARP1CES2CES1NPC1RAB9A
SCHEMBL1421198 0.85 CES2 (0.62) PARP1CES2CES1NPC1RAB9A
SCHEMBL2278242 0.85 CES2 (0.62) PARP1CES2CES1NPC1RAB9A
Urea SCHEMBL27916298 0.83 PARP1 (0.67) PARP1CES2CES1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed